 |
Medication Safety Officers Society 3680 Members Strong A society of healthcare professionals dedicated to improving medication safety in healthcare organizations |
PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).
Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.
We are interested in how other organizations handle the CMS/TJC/CIHQ requirement that "processes and mechanisms should e established to monitor patient responses to a newly added medication before the medication is made available for dispensing or administration within the hospital."
Do you have a blanket statement in policy that is applicable to every new drug, or do you define individual parameters for each new drug? If you would be willing to share policies that would be very helpful.